U.S. Auto Stock News

Label update and pipeline focus put Krystal Biotech in the spotlight Recent attention on Krystal Biotech (KRYS) centers on the FDA approval of an updated label for its gene therapy B-VEC/YJUVEK and on anticipation around its KB803 candidate for epidermolysis bullosa. See our latest analysis for Krystal Biotech. The recent FDA label update for B-VEC/YJUVEK and attention on KB803 come after a 36.79% 1 year total shareholder return. The 30 day share price return of 10.37% contrasts with a...

Wondering whether Owens Corning at around US$103 per share still offers value, or if the best days for this price are behind it? This article focuses squarely on what the current valuation is really telling you. The stock is roughly flat over the last week at a 0.3% gain, but that comes after a 22.6% decline over 30 days and a 28.0% decline over the past year, which can change how investors think about both risk and potential future returns. Recent headlines around Owens Corning have...

TAT Technologies (NasdaqGM:TATT) has wrapped up FY 2025 with fourth quarter revenue of US$46.5 million and basic EPS of US$0.36, capping a year in which trailing 12 month revenue reached US$178.0 million and EPS came in at US$1.39. Over recent periods the company has seen quarterly revenue move from US$41.0 million in Q4 2024 to US$46.5 million in Q4 2025. Basic EPS was US$0.36 a year ago and US$0.36 this quarter on a quarterly basis, and moved from US$1.08 to US$1.39 on a trailing 12 month...

Halliburton (HAL) is back in focus after reporting the industry’s first fully automated geological well placement offshore Guyana, a project that paired rig automation with real-time hydraulics to lift drilling efficiency. See our latest analysis for Halliburton. Halliburton’s recent Guyana automation milestone has arrived alongside firm price momentum, with the share price at $36.93 and a 90 day share price return of 33.23%, while the 1 year total shareholder return of 51.83% reflects recent...

Strive Asset Management (ASST) FY 2025 earnings snapshot Strive Asset Management (ASST) has just wrapped up FY 2025 with Q4 total revenue of about US$1.3 million and a loss per share of US$6.17, alongside a net loss excluding extra items of US$205.6 million, setting a stark backdrop for the latest numbers. Over the past year, revenue has moved from roughly US$0.8 million in Q2 2024 to US$1.3 million in Q4 2025, while trailing twelve month EPS shifted from a US$194.99 loss to a US$12.74 loss...

Why Modine Manufacturing is on investors’ radar Modine Manufacturing (MOD) has drawn attention after recent share price swings, including a one-month return of 7% and a gain of 47.5% over the past three months, prompting fresh questions about what is already priced into the stock. See our latest analysis for Modine Manufacturing. At a share price of $200.87, Modine’s recent 4.66% 7 day share price return and 42.65% year to date share price return sit alongside a very large 5 year total...

On March 9, 2026, Life Time Group Holdings announced that Class I director Alejandro Santo Domingo would resign from its board effective March 31, 2026, while KeyBanc Capital Markets began covering the company with an Overweight rating amid favorable fitness-industry conditions. The coverage initiation underscores Life Time’s positioning as a premium fitness brand benefiting from rising interest in holistic health and wellness across age groups. Next, we’ll examine how KeyBanc’s positive...

In recent days, Enterprise Products Partners reported better-than-expected Q4 2025 results, including record quarterly EBITDA of US$2.70 billion, supported by new assets coming online and strong contract coverage across its Permian processing and export terminals. Management’s guidance for US$1.00 billion in free cash flow during 2026, with a large portion earmarked for buybacks and growth projects, highlights how its fee-based midstream model may reinforce cash generation even when...

Southwest Airlines recently entered into a new US$500 million senior secured term loan facility maturing in 2029, backed by a pool of aircraft and related assets, while also presenting stronger-than-expected Q4 2025 results and raising its earnings outlook for 2026. This combination of fresh secured funding capacity and upgraded profitability guidance highlights how Southwest is simultaneously shoring up its balance sheet and signaling operating momentum. Next, we’ll examine how Southwest’s...

If you are wondering whether Nebius Group's current share price reflects its true worth, the recent trading history gives you plenty to think about. The stock last closed at US$121.52, with returns of 12.5% over 7 days, 24.6% over 30 days, 35.1% year to date, and 364.3% over the past year. This will naturally raise questions about how much of the story is already priced in. Recent attention around Nebius Group has focused on its role in the software sector and how investors are treating high...

Titan Machinery FY 2026 earnings snapshot Titan Machinery (TITN) has wrapped up FY 2026 with fourth quarter revenue of US$641.8 million and a basic EPS loss of US$1.59, while the trailing twelve months show revenue of US$2.4 billion and a basic EPS loss of US$2.38. Over recent quarters the company has seen revenue move from US$759.9 million in Q4 FY 2025 to US$641.8 million in Q4 FY 2026, with quarterly EPS swinging between a small profit of US$0.05 in Q3 FY 2026 and losses in the other...

Caleres (CAL) closed out FY 2026 with fourth quarter revenue of US$695.1 million and a basic EPS loss of US$0.68, while trailing twelve month revenue sat at about US$2.8 billion with a TTM basic EPS loss of US$0.21. Over recent quarters, the company has seen quarterly revenue move between US$614.2 million and US$790.1 million, with basic EPS ranging from a profit of US$0.21 in Q1 2026 to a loss of US$0.68 in Q4. This sets up a story where top line scale is in place but margin pressure is...

Tejon Ranch (TRC) has just wrapped up FY 2025 with fourth quarter revenue of US$21.1 million and basic EPS of US$0.06, while the full year on a trailing 12 month basis came in at US$49.6 million of revenue and essentially breakeven EPS around US$0.00. Over recent quarters, the company has seen revenue move from US$8.3 million and basic EPS of a US$0.06 loss in Q2 2025 to US$11.0 million and a US$0.06 loss in Q3 2024, before reaching Q4 2025’s US$21.1 million and US$0.06 EPS. This sets up a...

In early March 2026, FTI Consulting’s Technology segment reported growing adoption of its IQ.AI platform among major corporate legal departments and law firms and introduced IQ.AI Studio, a proprietary library of generative AI tasks, models and workflows for complex legal, regulatory and investigation matters across multiple regions. The company highlighted that IQ.AI has already been used on hundreds of matters to compress timelines, reduce manual review workloads and extract structured...

Baxter International (BAX) is back in focus after chief financial officer Joel Grade stepped down. Interim CFO Anita Zielinski is stepping in as legal and governance questions around the Novum LVP infusion pump draw fresh investor attention. See our latest analysis for Baxter International. The share price has retreated sharply to US$16.66, with a 30 day share price return of a 19.67% decline and a 1 year total shareholder return of a 49.50% loss, reflecting fading momentum as investors...

Recently, Photronics reported a strong quarter with revenue increasing 6.1% year on year, surpassing analyst estimates for both sales and earnings per share. Management also emphasized that facility expansion and efforts to broaden the company’s geographic revenue mix are progressing, reflecting how it is adapting its photomask business to a more regionally segmented semiconductor industry. With this earnings beat and reaffirmed progress on facility expansion, we’ll now examine how the...

GameStop’s acquisition speculation and transformation plans draw investor focus GameStop (GME) is back in the spotlight as speculation over a possible acquisition of a publicly traded consumer company intersects with CEO Ryan Cohen’s push toward e-commerce, collectibles, and accelerated store closures. See our latest analysis for GameStop. Speculation around a potential acquisition and Cohen’s push to reshape the business have arrived during a choppy period for the stock. The share price has...

Accenture (ACN) has reported Q2 2026 results with revenue of US$18.0b and basic EPS of US$2.96, setting the tone for how its consulting and technology services engine is currently translating into top and bottom line performance. The company has seen quarterly revenue move from US$16.7b in Q2 2025 to US$18.0b in Q2 2026, while basic EPS over the same quarters has shifted from US$2.85 to US$2.96, giving investors a clear read on how sales and earnings are tracking together. With a trailing net...

Movado Group (MOV) has wrapped up FY 2026 with fourth quarter revenue of US$191.6 million and basic EPS of US$0.55, supported by trailing twelve month revenue of US$671.3 million and EPS of US$1.17, alongside a 44.6% earnings increase over the past year. Over recent quarters, the company has seen revenue move from US$174.7 million and EPS of US$0.30 in Q4 FY 2025 to US$191.6 million and EPS of US$0.55 in Q4 FY 2026. At the same time, trailing net profit margin has shifted from 2.8% to 4%,...

Why IDT Is On Investors’ Radar Today IDT (IDT) has drawn fresh attention after recent trading saw mixed short term share performance, with a 1 day gain alongside weaker moves over the week, month and past 3 months. That divergence, combined with its current US$47.79 share price and roughly US$1.18b market cap, is prompting closer scrutiny of how the company’s communications and payments segments are contributing to revenue and earnings. See our latest analysis for IDT. Set against a 1 day...

A class action lawsuit has been filed against Soleno Therapeutics (NasdaqCM:SLNO) alleging failures to disclose significant safety concerns in clinical trials for its drug DCCR. The complaint targets the company and certain executives, claiming that undisclosed issues could affect DCCR's commercial prospects and Soleno's reputation. The case focuses on the period around the development and launch preparations of DCCR, Soleno's sole commercial product. Soleno Therapeutics is a biotech...

Aveanna Healthcare Holdings (AVAH) delivers full year 2025 results Aveanna Healthcare Holdings (AVAH) has wrapped up FY 2025 with fourth quarter revenue of US$662.5 million, basic EPS of US$0.85 and net income excluding extraordinary items of US$178.8 million. This frames a year where trailing twelve month revenue reached about US$2.4 billion and basic EPS was US$1.11. Over recent periods the company has seen revenue move from US$519.9 million in Q4 FY 2024 to US$662.5 million in Q4 FY 2025,...

Oracle (ORCL) has been back in focus after reporting financial results that topped expectations, paired with strong guidance, large AI related contract backlogs, and fresh product launches across healthcare and developer tools. See our latest analysis for Oracle. Despite upbeat earnings and AI headlines, Oracle’s 1 day share price return of 1.71% and 90 day share price return of 18.99% show that recent momentum still lags its earlier surge. At the same time, the 5 year total shareholder...

Yiren Digital’s FY 2025 Results Put Margins Under the Microscope Yiren Digital (NYSE:YRD) has just closed out FY 2025 with fourth quarter revenue of C¥957.6 million and a loss per share of C¥10.12, as net income excluding extra items came in at a loss of C¥882.2 million against a C¥2.03 share price. The company has seen quarterly revenue range from C¥1,652.1 million in Q2 2025 to C¥1,452.2 million in Q4 2024. Basic EPS moved from a profit of C¥3.84 in Q4 2024 to a loss in the latest quarter,...